White paper: Streamlining Pharma Operations in the Wake of COVID-19

Published: 13-Oct-2020

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris

NSF's white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment.

He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.

Click here to download the white paper.

You may also like